NCT01301508 - Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

November 11, 2011

Study Completion Date

November 11, 2011

Conditions

Dermatitis, Atopic

Interventions

DRUG

AN2728 ointment, 2%

AN2728 ointment, 2%, applied twice daily for 6 weeks

DRUG

AN2898 ointment, 1%

AN2898 ointment, 1%, applied twice daily for 6 weeks

DRUG

AN2898 ointment vehicle

AN2898 ointment vehicle applied twice daily for 6 weeks

DRUG

AN2728 ointment vehicle

AN2728 ointment vehicle applied twice daily for 6 weeks

Trial Locations (13)

2217

Anacor Investigational Site, Kogarah

3050

Anacor Investigational Site, Parkville

3053

Anacor Investigational Site, Carlton

3065

Anacor Investigational Site, Fitzroy

3128

Anacor Investigational Site, Box Hill

3168

Anacor Investigational Site, Clayton

4000

Anacor Investigational Site, Brisbane

4102

Anacor Investigational Site, Woolloongabba

5000

Anacor Investigational Site, Adelaide

6008

Anacor Investigational Site, Subiaco

6009

Anacor Investigational Site, Nedlands

6100

Anacor Investigational Site, Victoria Park

6160

Anacor Investigational Site, Fremantle